Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C S Coupling. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel metal-free synthesis of methylthiomethyl esters using DMSO. Cost-effective, scalable pharmaceutical intermediate manufacturing with high purity standards.
Patent CN112266365A reveals a metal-free oxidative coupling method for high-purity phenoxazine intermediates, offering significant cost reduction in organic photoelectric material manufacturing.
Novel Ni-catalyzed method for trifluoroethylation using cheap 2-chloro-1,1,1-trifluoroethane. Mild conditions, high yield, suitable for pharma intermediates.
Patent CN109438402B discloses a green catalytic route for benzofuranone derivatives. High yield, low cost, scalable process ideal for pharmaceutical intermediates manufacturing.
Novel Ni-catalyzed route for Bilastine intermediate II. High yield, low cost, scalable process replacing Palladium methods for pharmaceutical manufacturing.
Novel nitro-based cross-coupling method eliminates halogen waste. Offers cost reduction in pharmaceutical intermediate manufacturing and high-purity aromatic compounds for global supply chains.
Patent CN112174832A details a novel one-step Pd-catalyzed methylation route for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Patent CN106008582A reveals stable BODIPY derivatives for solar cells. Offers supply chain reliability and cost-effective manufacturing for electronic chemical partners.
Patent CN107235910B reveals a high-purity synthesis route for Nilotinib intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.
Patent CN109666044B discloses rigid [2.2]paracyclophane ligands enabling efficient asymmetric catalysis with scalable synthesis routes for industrial applications.
Patent CN118754905B reveals nickel catalysis for silane synthesis. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing supply chain.
Novel 3,5-dialkyl pyrazole ligand enables C-Cl greater than C-OTf selectivity in Buchwald-Hartwig reactions, offering cost-effective pharma intermediate synthesis.
Patent CN110372544B details a cost-effective iron-titanium catalytic system for biaryl synthesis, offering significant supply chain stability and reduced environmental impact.
Patent CN112939829A reveals a copper-catalyzed method for aryl trifluoromethyl thioethers, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN110143982A reveals green synthesis. Cost reduction and supply reliability for high-purity organophosphorus intermediates in global markets.
Patent CN103864567A details a green method for biaryl synthesis using reusable heterogeneous palladium catalysts, offering significant cost and supply chain advantages.
Patent CN101891647A details a novel Ubenimex preparation using L-lysine resolution and EDCI/HOAt coupling, ensuring >99.5% purity and robust supply chain reliability.
Patent CN111087344A discloses a green synthesis for diaziridine-amino acid conjugates. This report analyzes the scalable route for high-purity pharmaceutical intermediates.
Patent CN108864164B details a green Pd-catalyzed method for 2-alkynyl indoles using water solvent, offering high regioselectivity and cost-effective manufacturing for pharma intermediates.
Patent CN108620130B reveals a stable o-carborane iridium catalyst for green imine synthesis, offering significant cost reduction and supply chain reliability for pharma manufacturing.